april 22 semaglutide On February 21, 2025, the FDA announced that semaglutide, the active ingredient in Ozempic and Wegovy, is no longer considered in shortage, signaling an improvement in national supply. As a result, compounding The Semaglutide Shortage Is Ending:

Derosa G, DAngelo A, Maffioli P

We know when we manage our patients with type 2 diabetes, we not only need to be concerned about glycemic control, but also about reducing cardiometabolic risk as well as weight reduction since most of our patients are overweight or obese, Juan P

If you still need help managing your blood sugar levels your dose will increase to 14mg once a day

This table illustrates a clear progression

Insurance companies may not cover it because they typically only cover FDA-approved medications and dosing

But today's GLP-1s are more powerful and wholly different from earlier types of weight-loss drugs, DeCaro says